Targeting LncRNA938/TAF9/TTK Axis Enhances Hepatoblastoma Treatment
In the evolving landscape of cancer research, new and groundbreaking findings continue to emerge, which challenge the boundaries of our understanding of tumor biology. A...
NEWS INDEX
Refining Bat Species Identification with VGG16-CBAM
In a groundbreaking study published in Front Zool, researchers have unveiled a revolutionary approach to fine-grained image classification of bats, a group often overlooked despite...
Promising Outcomes from First-in-Human Trial of DLL3-Targeted Antibody-Drug Conjugate SHR-4849 in Relapsed Small Cell Lung Cancer
First-in-Human Trial Highlights Breakthrough DLL3-Targeted Therapy for Relapsed Small Cell Lung Cancer In a landmark development in the treatment of relapsed small cell lung cancer...
Phase 2 IDeate-Lung01 Trial Shows Ifinatamab Deruxtecan Achieves High Response Rates in Previously Treated Extensive-Stage Small Cell Lung Cancer
In a groundbreaking advancement for small cell lung cancer (SCLC) therapy, recent data unveiled at the International Association for the Study of Lung Cancer (IASLC)...
Pilot Intervention to Support Caregivers of Schizophrenic Seniors
Recent research has highlighted a critical but frequently overlooked aspect of mental health care—the impact on family caregivers of older adults diagnosed with schizophrenia. The...
Gender Disparities in OSA: Endocrine, Metabolic, Psychological Effects
Sex Differences in Endocrine, Metabolic, and Psychological Disturbances in Obese Patients with Obstructive Sleep Apnea In a groundbreaking study published in Biology of Sex Differences,...
LPS-TLR4 Axis: Gut Dysbiosis and Heart Failure Insights
In recent years, researchers have increasingly acknowledged the intricate relationship between the gut microbiota and various physiological processes, particularly pertaining to cardiovascular health. One of...
Memantine Alleviates Methamphetamine Memory Deficits in Rats
In the intricate world of neuroscience, the effects of addictive substances on cognitive functions are a matter of paramount concern. A recent study conducted by...
Honey Bee Antenna Protein Critical for Olfactory Behavior
In a groundbreaking study published in Front Zool, researchers led by Liu, F., along with co-authors Lai, Y., and Wu, L., have unveiled the intricate...
EDE-Q7: Evaluación de Trastornos Alimentarios en Adultos
In recent years, the growing concern surrounding eating disorders has captured the attention of researchers worldwide. The Spanish version of the Brief Eating Disorder Examination...
Zidesamtinib Demonstrates Lasting Efficacy in ROS1 TKI-Pretreated NSCLC, Including Cases with CNS Involvement and ROS1 G2032R Mutations
In a groundbreaking advancement for the treatment of ROS1-positive non-small cell lung cancer (NSCLC), a novel investigational agent, zidesamtinib, has demonstrated remarkable efficacy and durability,...
Crizotinib Does Not Enhance Disease-Free Survival in Resected Early-Stage ALK-Positive NSCLC
In a significant development in the field of thoracic oncology, recent findings from the Phase 3 E4512 clinical trial have revealed that crizotinib, a well-established...
FLAURA2 Trial Demonstrates Enhanced Overall Survival with Osimertinib and Chemotherapy in EGFR-Mutated Advanced NSCLC
In a groundbreaking advancement within the realm of targeted oncology, the international cancer research community has witnessed compelling evidence supporting the enhanced efficacy of combining...
Ivonescimab Combined with Chemotherapy Enhances Progression-Free Survival in EGFR-Positive NSCLC Patients After Third-Generation EGFR-TKI Treatment
In a groundbreaking advancement for the management of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations, the addition of ivonescimab—a...
Aumolertinib Combined with Chemotherapy Enhances Progression-Free Survival in NSCLC Patients Harboring EGFR and Tumor Suppressor Gene Alterations: Findings from the ACROSS 2 Phase III Trial
Groundbreaking Phase III Trial Demonstrates Superior Efficacy of Aumolertinib Plus Chemotherapy in Advanced EGFR-Mutant NSCLC In a pivotal advancement for the treatment of advanced non-small...
